John Zalcberg

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Val Gebski, John Simes, V. Gebski, 2007, The Lancet. Oncology.

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Rossella Bertulli, Jean-Yves Blay, Ian Judson, 2004, The Lancet.

Delivering affordable cancer care in high-income countries.

Karol Sikora, Peter Boyle, Paul Catchpole, 2011, The Lancet. Oncology.